{
    "organizations": [],
    "uuid": "56051b1d90c3f64a47b3b0dcb3cf3fe94ac160ed",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-five-prime-reports-q4-loss-per-sha/brief-five-prime-reports-q4-loss-per-share-1-04-idUSASB0C7SX",
    "ord_in_thread": 0,
    "title": "BRIEF-Five Prime Reports Q4 Loss Per Share $1.04",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 27 (Reuters) - Five Prime Therapeutics Inc:\n* FIVE PRIME ANNOUNCES FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS\n* Q4 LOSS PER SHARE $1.04 * FIVE PRIME THERAPEUTICS - CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES TOTALED $292.7 MILLION ON DEC 31, 2017 VERSUS $421.7 MILLION ON DECEMBER 31, 2016 Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-28T06:04:00.000+02:00",
    "crawled": "2018-02-28T13:03:18.003+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "five",
        "prime",
        "therapeutic",
        "inc",
        "five",
        "prime",
        "announces",
        "fourth",
        "quarter",
        "full",
        "year",
        "financial",
        "result",
        "q4",
        "loss",
        "per",
        "share",
        "five",
        "prime",
        "therapeutic",
        "cash",
        "cash",
        "equivalent",
        "marketable",
        "security",
        "totaled",
        "million",
        "dec",
        "versus",
        "million",
        "december",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}